First Evaluation of PET-Based Human Biodistribution and Dosimetry of 18F-FAZA, a Tracer for Imaging Tumor Hypoxia

18F-labeled fluoroazomycinarabinoside (18F-FAZA) is a PET biomarker for noninvasive identification of regional tumor hypoxia. The aim of the present phase I study was to evaluate the biodistribution and dosimetry of 18F-FAZA in non-small cell lung cancer patients. Methods: Five patients awaiting sur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of nuclear medicine (1978) 2017-08, Vol.58 (8), p.1224-1229
Hauptverfasser: Savi, Annarita, Incerti, Elena, Fallanca, Federico, Bettinardi, Valentino, Rossetti, Francesca, Monterisi, Cristina, Compierchio, Antonia, Negri, Giampiero, Zannini, Piero, Gianolli, Luigi, Picchio, Maria
Format: Artikel
Sprache:eng ; jpn
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!